Beta-lactams
Beta-lactam antibiotics are the most popular antibacterial agents used for treating bacterial infections, due to their great activity, broad spectrum, and safety profile. All of them share the beta-lactam ring and because of the particular chemical structure, they are classified into five groups: Pe...
| Autores: | , , |
|---|---|
| Tipo de recurso: | capítulo de libro |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Universidad Autónoma de Madrid |
| Repositorio: | Biblos-e Archivo. Repositorio Institucional de la UAM |
| Idioma: | inglés |
| OAI Identifier: | oai:repositorio.uam.es:10486/738940 |
| Acceso en línea: | https://hdl.handle.net/10486/738940 https://dx.doi.org/10.1002/9781119282549.ch3 |
| Access Level: | acceso abierto |
| Palabra clave: | penicillins cephalosporins monobactams carbapenems PBPs betalactamases carbapenemases ceftazidime-avibactam ceftolozane-tazobactam ceftaroline Medicina |
| id |
ES_da1b6a61a4f9d8b44cdfb78298c04df0 |
|---|---|
| oai_identifier_str |
oai:repositorio.uam.es:10486/738940 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Beta-lactamsBalsalobre, LuzBlanco, AnaAlarcón Cavero, TeresapenicillinscephalosporinsmonobactamscarbapenemsPBPsbetalactamasescarbapenemasesceftazidime-avibactamceftolozane-tazobactamceftarolineMedicinaBeta-lactam antibiotics are the most popular antibacterial agents used for treating bacterial infections, due to their great activity, broad spectrum, and safety profile. All of them share the beta-lactam ring and because of the particular chemical structure, they are classified into five groups: Penicillins (natural and semisynthetic), cephalosporins (first-, second-, third-, fourth-, and fifth-generation), monobactams, carbapenems and the association of a beta-lactam with a beta-lactamase inhibitor (Beta-lactam and non-beta-lactam inhibitors). Carbapenems have a carbon atom instead of a sulfur or an oxygen atom in the bicyclic nucleus and a hydroxyethyl side chain in trans configuration at position 6 and are the widest spectrum antibiotics available among the beta-lactams. Beta-lactams are bactericidal agents that kill bacteria by inhibiting the synthesis of the cell wall in both Gram-negative and Gram-positive bacteria, interacting with PBPs, so the transpeptidation reaction is blockaded, leading to the cell lysis and death. As a consequence of the widespread use of this antibiotics, bacterial resistance is a growing problem in both community and hospital settings. Emergence and dissemination of beta-lactam resistance have renewed interest in the development of novel beta-lactam antibiotics or beta-lactamase inhibitors, and some of them are currently available for multi-resistant bacteria treatmentWileyCapelo Martínez, José LuisIgrejas, GilbertoDepartamento de Medicina Preventiva y Salud Pública y MicrobiologíaFacultad de Medicina20192019-08-23book parthttp://purl.org/coar/resource_type/c_3248AMhttp://purl.org/coar/version/c_ab4af688f83e57aainfo:eu-repo/semantics/bookPartapplication/pdfhttps://hdl.handle.net/10486/738940https://dx.doi.org/10.1002/9781119282549.ch3reponame:Biblos-e Archivo. Repositorio Institucional de la UAMinstname:Universidad Autónoma de MadridInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:repositorio.uam.es:10486/7389402026-06-23T12:46:27Z |
| dc.title.none.fl_str_mv |
Beta-lactams |
| title |
Beta-lactams |
| spellingShingle |
Beta-lactams Balsalobre, Luz penicillins cephalosporins monobactams carbapenems PBPs betalactamases carbapenemases ceftazidime-avibactam ceftolozane-tazobactam ceftaroline Medicina |
| title_short |
Beta-lactams |
| title_full |
Beta-lactams |
| title_fullStr |
Beta-lactams |
| title_full_unstemmed |
Beta-lactams |
| title_sort |
Beta-lactams |
| dc.creator.none.fl_str_mv |
Balsalobre, Luz Blanco, Ana Alarcón Cavero, Teresa |
| author |
Balsalobre, Luz |
| author_facet |
Balsalobre, Luz Blanco, Ana Alarcón Cavero, Teresa |
| author_role |
author |
| author2 |
Blanco, Ana Alarcón Cavero, Teresa |
| author2_role |
author author |
| dc.contributor.none.fl_str_mv |
Capelo Martínez, José Luis Igrejas, Gilberto Departamento de Medicina Preventiva y Salud Pública y Microbiología Facultad de Medicina |
| dc.subject.none.fl_str_mv |
penicillins cephalosporins monobactams carbapenems PBPs betalactamases carbapenemases ceftazidime-avibactam ceftolozane-tazobactam ceftaroline Medicina |
| topic |
penicillins cephalosporins monobactams carbapenems PBPs betalactamases carbapenemases ceftazidime-avibactam ceftolozane-tazobactam ceftaroline Medicina |
| description |
Beta-lactam antibiotics are the most popular antibacterial agents used for treating bacterial infections, due to their great activity, broad spectrum, and safety profile. All of them share the beta-lactam ring and because of the particular chemical structure, they are classified into five groups: Penicillins (natural and semisynthetic), cephalosporins (first-, second-, third-, fourth-, and fifth-generation), monobactams, carbapenems and the association of a beta-lactam with a beta-lactamase inhibitor (Beta-lactam and non-beta-lactam inhibitors). Carbapenems have a carbon atom instead of a sulfur or an oxygen atom in the bicyclic nucleus and a hydroxyethyl side chain in trans configuration at position 6 and are the widest spectrum antibiotics available among the beta-lactams. Beta-lactams are bactericidal agents that kill bacteria by inhibiting the synthesis of the cell wall in both Gram-negative and Gram-positive bacteria, interacting with PBPs, so the transpeptidation reaction is blockaded, leading to the cell lysis and death. As a consequence of the widespread use of this antibiotics, bacterial resistance is a growing problem in both community and hospital settings. Emergence and dissemination of beta-lactam resistance have renewed interest in the development of novel beta-lactam antibiotics or beta-lactamase inhibitors, and some of them are currently available for multi-resistant bacteria treatment |
| publishDate |
2019 |
| dc.date.none.fl_str_mv |
2019 2019-08-23 |
| dc.type.none.fl_str_mv |
book part http://purl.org/coar/resource_type/c_3248 AM http://purl.org/coar/version/c_ab4af688f83e57aa |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/bookPart |
| format |
bookPart |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/10486/738940 https://dx.doi.org/10.1002/9781119282549.ch3 |
| url |
https://hdl.handle.net/10486/738940 https://dx.doi.org/10.1002/9781119282549.ch3 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley |
| publisher.none.fl_str_mv |
Wiley |
| dc.source.none.fl_str_mv |
reponame:Biblos-e Archivo. Repositorio Institucional de la UAM instname:Universidad Autónoma de Madrid |
| instname_str |
Universidad Autónoma de Madrid |
| reponame_str |
Biblos-e Archivo. Repositorio Institucional de la UAM |
| collection |
Biblos-e Archivo. Repositorio Institucional de la UAM |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869421521815994368 |
| score |
15.812429 |